Ziihera Alternatives Compared
| Ziihera (zanidatamab) | Imfinzi (durvalumab) | Tibsovo (ivosidenib) |
|
|---|
| Ziihera (zanidatamab) | Imfinzi (durvalumab) | Tibsovo (ivosidenib) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Biliary Tract Tumor. Ziihera may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Small Cell Lung Cancer, Non Small Cell Lung Cancer, Biliary Tract Tumor, Hepatocellular Carcinoma, Endometrial Cancer, Bladder Cancer. Imfinzi may also be used for purposes not listed... View more |
Prescription only
Prescribed for Biliary Tract Tumor, Myelodysplastic Syndrome, Acute Myeloid Leukemia. Tibsovo may also be used for purposes not listed in this medication guide. |
Related suggestions Biliary Tract Tumor
|
|||||||||||||||||||||||
| More about Ziihera (zanidatamab) | More about Imfinzi (durvalumab) | More about Tibsovo (ivosidenib) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Imfinzi has an average rating of 8.7 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Ziihera side effects |
View all Imfinzi side effects |
View all Tibsovo side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ziihera prices |
View all Imfinzi prices |
View all Tibsovo prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
504 hours |
408 hours |
129 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 175 drugs are known to interact with Ziihera:
|
A total of 624 drugs are known to interact with Imfinzi:
|
A total of 580 drugs are known to interact with Tibsovo:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 20, 2024 |
May 01, 2017 |
July 20, 2018 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Herceptin Hylecta
Herceptin Hylecta is a type of targeted immunotherapy used in the treatment of human epidermal ...
Hercessi
Hercessi (trastuzumab-strf) is the 6th biosimilar to Herceptin to be granted FDA approval and may ...
Herzuma
Herzuma is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, esophageal ...
Kadcyla
Kadcyla (ado-trastuzumab emtansine) is used to treat HER2-positive breast cancer. Includes Kadcyla ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.